Hold control (command on a Mac) and press the + key as many times as necessary to increase the font size.
Hold control (command on a Mac) and press the - key to reduce the font size. - hide
Online Bulletin Board Support Group Users: click "Forum" to view archives and post messages. - hide
Show/Hide

Patient Education Events Coming to Baltimore and Boston!

Oct. 8, 2017

Registration is now open for our FREE patient education events in Baltimore and Boston!

Baltimore: Sunday, Oct. 8th (during the ThyCa annual meeting for thyroid cancer survivors).
Click here for Baltimore Registration.

Boston: Saturday, Oct. 14th (co-hosted by Massachusetts Eye and Ear).
Click here for Boston Registration.

Please note that both events are free to attend. Boxed lunches may be purchased in advance for the Baltimore event.  Details will be coming shortly.

Read More

  • Patient Education Events Coming to Baltimore and Boston!

    Oct. 8, 2017

    Registration is now open for our FREE patient education events in Baltimore and Boston!

    Baltimore: Sunday, Oct. 8th (during the ThyCa annual meeting for thyroid cancer survivors).
    Click here for Baltimore Registration.

    Boston: Saturday, Oct. 14th (co-hosted by Massachusetts Eye and Ear).
    Click here for Boston Registration.

    Please note that both events are free to attend. Boxed lunches may be purchased in advance for the Baltimore event.  Details will be coming shortly.

    Read More

  • Thyroid Eye Disease Breakthrough!

    June 30, 2017

    If you've been diagnosed with thyroid eye disease, you know that the current options leave much to be desired: wait, wait, wait, wait some more -- and eventually get approved for one or more surgeries to address bulging, swelling, and double vision. (With steroid therapy sometimes used as a temporary stopgap).  However, the successful trial of a brand new drug could prove to be a game-changer for patients living with this disfiguring and frustrating condition ...

    Read More

  • Wilmer Eye Institute Thyroid Eye Disease Study

    June 30, 2017

    The Johns Hopkins Wilmer Eye Institute is currently recruiting patients for a new clinical study using celecoxib (Celebrex), a non-steroidal anti-inflammatory drug approved by the Food and Drug Administration (FDA) for the treatment of pain, osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis, as a treatment for active thyroid eye disease (TED).  The study is intended to evaluate the efficacy of COX-2 inhibition in the treatment of active TED and its ability to improve both the acute ...

    Read More

  • Recent Forum Posts

Questions? Problems? Please contact us at info@ngdf.org or 877-643-3123.

GDATF on Facebook
Thank you to our Diamond Sponsors:
Quidel-Thyretain The Bell Charitable Foundation

Support the GDATF and become a member today!

© 2017 Graves' Disease & Thyroid Foundation